TickerFacts.

Integra Lifesciences Holdings Corp (IART): Free Cash Flow

Operating cash flow minus capital expenditures for the same annual period and currency, computed by TickerFacts from the filed figures. A simple proxy, not a reported figure; a year without both inputs is left out.

Restated years: each year's figure is from the latest filing that reports it. The company later restated the years ended 2013-12-31, 2014-12-31 (for example after a spin-off or a discontinued operation), while the year before each was last reported on the old basis. Changes across those points are marked n/c (not comparable), and growth rates are not computed across them.

-$31.05M
Year ended 2025-12-31
$25.80M
Trailing 12 months to 2026-06-30
$264.40M2008-12-31: $59.19M2009-12-31: $118.00M2010-12-31: $68.43M2011-12-31: $65.90M2012-12-31: -$9.93M2013-12-31: $10.97M2014-12-31: $45.23M2015-12-31: $71.44M2016-12-31: $69.08M2017-12-31: $71.04M2018-12-31: $121.94M2019-12-31: $161.90M2020-12-31: $164.94M2021-12-31: $264.40M2022-12-31: $222.13M2023-12-31: $73.09M2024-12-31: $24.96M2025-12-31: -$31.05M-$31.05M
2008-12-31 Free Cash Flow (USD) 2025-12-31
Period endedFree Cash FlowChange YoYSource filing
2025-12-31-$31.05Mn/m2026-02-26, From 2025-01-01
2024-12-31$24.96M-65.8%2026-02-26, From 2024-01-01
2023-12-31$73.09M-67.1%2026-02-26, From 2023-01-01
2022-12-31$222.13M-16.0%2025-02-25, From 2022-01-01
2021-12-31$264.40M+60.3%2024-02-28, From 2021-01-01
2020-12-31$164.94M+1.9%2023-02-22, From 2020-01-01
2019-12-31$161.90M+32.8%2022-02-24, From 2019-01-01
2018-12-31$121.94M+71.7%2021-02-23, From 2018-01-01
2017-12-31$71.04M+2.8%2020-02-21, From 2017-01-01
2016-12-31$69.08M-3.3%2019-02-26, From 2016-01-01
2015-12-31$71.44M+58.0%2018-03-01, From 2015-01-01
2014-12-31$45.23Mn/c2017-02-23, From 2014-01-01
2013-12-31$10.97Mn/c2016-02-26, From 2013-01-01
2012-12-31-$9.93Mn/m2015-02-27, From 2012-01-01
2011-12-31$65.90M-3.7%2014-02-27, From 2011-01-01
2010-12-31$68.43M-42.0%2013-02-26, From 2010-01-01
2009-12-31$118.00M+99.4%2012-02-27, From 2009-01-01
2008-12-31$59.19Mn/a2011-02-24, From 2008-01-01

Free Cash Flow at similar companies

Companies with the same SEC industry code (Surgical & Medical Instruments & Apparatus), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedFree Cash FlowChange YoY
Integra Lifesciences Holdings Corp (IART)2025-12-31-$31.05Mn/m
Merit Medical Systems Inc (MMSI)2025-12-31$215.66M+16.2%
Penumbra Inc (PEN)2025-12-31$174.93M+18.8%
Teleflex Inc (TFX)2025-12-31$1.45M-99.3%
Haemonetics Corp (HAE)2026-03-28$260.44M+82.8%
ICU Medical Inc (ICUI)2025-12-31$91.80M-26.4%
Embecta Corp. (EMBC)2025-09-30$182.40M+816.6%
Tandem Diabetes Care Inc (TNDM)2025-12-31-$29.67Mn/m
Insulet Corp (PODD)2025-12-31$377.70M+23.7%

Compare IART, MMSI, PEN, TFX side by side · Screen every company in Surgical & Medical Instruments & Apparatus ↗